Grail (GRAL) Competitors $42.15 +2.12 (+5.30%) Closing price 04:00 PM EasternExtended Trading$41.67 -0.48 (-1.13%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and WGSShould you be buying Grail stock or one of its competitors? The main competitors of Grail include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Grail vs. Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent LifeStance Health Group GeneDx Grail (NASDAQ:GRAL) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation, institutional ownership and community ranking. Does the MarketBeat Community prefer GRAL or OPCH? Option Care Health received 62 more outperform votes than Grail when rated by MarketBeat users. Likewise, 64.00% of users gave Option Care Health an outperform vote while only 33.33% of users gave Grail an outperform vote. CompanyUnderperformOutperformGrailOutperform Votes233.33% Underperform Votes466.67% Option Care HealthOutperform Votes6464.00% Underperform Votes3636.00% Do institutionals & insiders have more ownership in GRAL or OPCH? 98.1% of Option Care Health shares are owned by institutional investors. 1.9% of Grail shares are owned by insiders. Comparatively, 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate GRAL or OPCH? Grail currently has a consensus target price of $31.50, suggesting a potential downside of 21.31%. Option Care Health has a consensus target price of $35.50, suggesting a potential upside of 12.09%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Grail 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Is GRAL or OPCH more profitable? Option Care Health has a net margin of 4.37% compared to Grail's net margin of 0.00%. Option Care Health's return on equity of 15.30% beat Grail's return on equity.Company Net Margins Return on Equity Return on Assets GrailN/A N/A N/A Option Care Health 4.37%15.30%6.57% Which has stronger valuation & earnings, GRAL or OPCH? Option Care Health has higher revenue and earnings than Grail. Grail is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGrail$130.71M11.02-$2.19B-$60.99-0.66Option Care Health$5.19B1.00$267.09M$1.2425.54 Does the media prefer GRAL or OPCH? In the previous week, Grail had 18 more articles in the media than Option Care Health. MarketBeat recorded 21 mentions for Grail and 3 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.45 beat Grail's score of 0.68 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Grail 9 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOption Care Health beats Grail on 14 of the 17 factors compared between the two stocks. Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGrailMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.44B$3.18B$5.51B$8.63BDividend YieldN/A31.25%5.27%4.19%P/E Ratio-0.6615.0827.1920.15Price / Sales11.02167.15418.25161.58Price / CashN/A57.5638.2534.64Price / BookN/A4.776.964.72Net Income-$2.19B-$22.21M$3.23B$248.00M7 Day Performance3.84%2.73%5.20%3.71%1 Month Performance13.72%6.80%13.94%10.34%1 Year PerformanceN/A14.39%32.32%15.16% Grail Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGrail0.3814 of 5 stars$42.15+5.3%$31.50-25.3%N/A$1.52B$130.71M-0.691,360OPCHOption Care Health4.1306 of 5 stars$31.86-2.5%$35.50+11.4%+8.5%$5.22B$5.19B26.775,600Positive NewsGHGuardant Health3.2987 of 5 stars$42.10+3.6%$52.32+24.3%+72.8%$5.22B$774.00M-11.831,790Trending NewsInsider TradeRDNTRadNet3.577 of 5 stars$58.26+1.3%$69.75+19.7%-3.6%$4.37B$1.87B-832.178,970BTSGBrightSpring Health Services0.7857 of 5 stars$23.93+0.5%$23.56-1.6%+117.9%$4.17B$11.86B-92.0435,000News CoveragePositive NewsSHCSotera Health2.7457 of 5 stars$12.19-0.4%$15.80+29.6%+1.5%$3.46B$1.11B48.763,000Analyst DowngradeSGRYSurgery Partners2.8908 of 5 stars$23.39-0.9%$33.56+43.5%-8.2%$3.00B$3.17B-48.7312,200Positive NewsPRVAPrivia Health Group3.5533 of 5 stars$22.83+0.3%$27.77+21.6%+35.5%$2.78B$1.80B228.32810CONConcentra Group Holdings ParentN/A$21.44-0.9%$28.50+32.9%N/A$2.73B$1.93B16.0011,000Positive NewsLFSTLifeStance Health Group2.1113 of 5 stars$5.88-1.0%$8.50+44.6%+4.1%$2.29B$1.28B-22.626,640WGSGeneDx3.2764 of 5 stars$74.13+4.1%$86.75+17.0%+189.6%$2.12B$330.14M-37.821,200Positive News Related Companies and Tools Related Companies Option Care Health Alternatives Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives LifeStance Health Group Alternatives GeneDx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Urgent Crypto Market Alert The last time we saw this pattern, early investors made fortunes...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRAL Stock Free GRAL Stock Alerts